Profiling MT Inhibitors with Transzyme™ Methyltransferase Assay Kits

27 Oct 2014

Methyltransferases are challenging targets from an assay development standpoint because they have low activity, high SAM affinities, and complex acceptor substrate requirements. Profiling inhibitor selectivity across several isoforms is especially challenging as it requires a combination of high sensitivity and the ability to accommodate diverse substrates and widely variable reaction conditions. TheTranscreener® EPIGEN Methyltransferase Assay was developed to meet these needs. It is a universal, mix-and-read assay method with a far red fluorescence polarization readout that is capable of detecting SAH at low nanomolar concentrations. This poster presents results on development of Transzyme MT Assay kits for several protein and DNA methyltransferases including Dot1L, NSD2 and PRMT1 and 3 and their use in selective profiling of MT-focused inhibitor library.

Links

Tags

Assay AssemblyAssay Assembly is technique used in drug discovery to develop assays to test the cytotoxicity, genotoxicity, or other activities of a compound on a cell. Assay assembly requires chip assembly, a delivery system and a detection and analysis method. Beneficial features of assay kits or automated systems include high-throughput, high speed and sensitivity and low signal to noise ratio.Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.Assay DevelopmentThe process of proving an assay to be sensitive with respect to the target is known as assay development. The assay should be able to characterize novel compounds and measure the potency of these compounds against a validated biological target.
Profiling MT Inhibitors with Transzyme™ Methyltransferase Assay Kits